NO179328C - Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom - Google Patents

Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom

Info

Publication number
NO179328C
NO179328C NO901461A NO901461A NO179328C NO 179328 C NO179328 C NO 179328C NO 901461 A NO901461 A NO 901461A NO 901461 A NO901461 A NO 901461A NO 179328 C NO179328 C NO 179328C
Authority
NO
Norway
Prior art keywords
gene product
antibodies
retinoblastoma gene
murine hybridoma
retinoblastoma
Prior art date
Application number
NO901461A
Other languages
English (en)
Other versions
NO179328B (no
NO901461D0 (no
NO901461L (no
Inventor
Yuen Kai Fung
Ang Anne T
Original Assignee
Canji Inc
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc, Res Dev Foundation filed Critical Canji Inc
Publication of NO901461D0 publication Critical patent/NO901461D0/no
Publication of NO901461L publication Critical patent/NO901461L/no
Publication of NO179328B publication Critical patent/NO179328B/no
Publication of NO179328C publication Critical patent/NO179328C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
NO901461A 1989-03-31 1990-03-30 Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom NO179328C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33208289A 1989-03-31 1989-03-31

Publications (4)

Publication Number Publication Date
NO901461D0 NO901461D0 (no) 1990-03-30
NO901461L NO901461L (no) 1990-10-01
NO179328B NO179328B (no) 1996-06-10
NO179328C true NO179328C (no) 1996-09-18

Family

ID=23296661

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901461A NO179328C (no) 1989-03-31 1990-03-30 Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom

Country Status (15)

Country Link
EP (1) EP0390530B1 (no)
JP (1) JPH04193900A (no)
KR (1) KR0175658B1 (no)
CN (1) CN1046759A (no)
AT (1) ATE122723T1 (no)
AU (1) AU638238B2 (no)
CA (1) CA2013544C (no)
DE (1) DE69019410T2 (no)
FI (1) FI901618A7 (no)
IE (1) IE63277B1 (no)
IL (1) IL93941A (no)
NO (1) NO179328C (no)
NZ (1) NZ233147A (no)
PT (1) PT93619A (no)
ZA (1) ZA902425B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710255A (en) * 1992-07-14 1998-01-20 Canji, Inc. Characterization of a novel anti-p110RB monoclonal antibody
US5550020A (en) * 1994-07-08 1996-08-27 Visible Genetics Inc. Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
US5545527A (en) * 1994-07-08 1996-08-13 Visible Genetics Inc. Method for testing for mutations in DNA from a patient sample
EP2014772A3 (en) * 1996-04-05 2009-05-27 Antonio Giordano Method for the diagnosis and prognosis of cancer
US5840506A (en) * 1996-06-05 1998-11-24 Thomas Jefferson University Methods for the diagnosis and prognosis of cancer
US20040225077A1 (en) 2002-12-30 2004-11-11 Angiotech International Ag Drug delivery from rapid gelling polymer composition
TW200741009A (en) 2005-07-01 2007-11-01 Oncotherapy Science Inc Methods of modulating SMYD3 for treatment of cancer
CN102053150B (zh) * 2009-10-30 2013-07-17 上海交通大学医学院附属瑞金医院 一种人成骨肉瘤干细胞相关抗原标记物及其应用
CN121471352A (zh) * 2025-11-15 2026-02-06 北京中杉金桥生物技术有限公司 一种抗人rb蛋白单克隆单体及其应用、杂交瘤细胞株和试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3163090B2 (ja) * 1988-01-21 2001-05-08 マサチューセッツ アイ アンド イヤー インファーマリー 網膜芽腫診断剤

Also Published As

Publication number Publication date
IL93941A0 (en) 1990-12-23
IE901179L (en) 1990-09-30
CA2013544C (en) 2001-02-06
NZ233147A (en) 1993-04-28
PT93619A (pt) 1990-11-20
FI901618A7 (fi) 1990-10-01
IL93941A (en) 1995-03-30
NO179328B (no) 1996-06-10
DE69019410T2 (de) 1995-10-05
JPH04193900A (ja) 1992-07-13
KR0175658B1 (ko) 1999-03-20
AU638238B2 (en) 1993-06-24
ATE122723T1 (de) 1995-06-15
NO901461D0 (no) 1990-03-30
KR900013987A (ko) 1990-10-22
EP0390530A1 (en) 1990-10-03
AU5246190A (en) 1990-10-04
CA2013544A1 (en) 1990-09-30
FI901618A0 (fi) 1990-03-30
IE63277B1 (en) 1995-04-05
ZA902425B (en) 1991-01-30
DE69019410D1 (de) 1995-06-22
NO901461L (no) 1990-10-01
CN1046759A (zh) 1990-11-07
EP0390530B1 (en) 1995-05-17

Similar Documents

Publication Publication Date Title
DE69429092D1 (de) Verfahren zur kontrolle von b-zellenpopulation
GB9824632D0 (en) Biological compounds
AU7074698A (en) Detection and modulation of the iaps and naip for the diagnosis and treatment ofproliferative disease
ATE132197T1 (de) Monoklonale antikörper
EP1364969A3 (en) Human tissue factor related DNA segments, polypeptides and antibodies
ATE365744T1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
SG96535A1 (en) Pharmaceutical composition for the treatment or prevention of a malignant tumor
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
GR3020610T3 (en) Monoclonal antibodies against tumor associated antigen, their preparation and use
CA2082382A1 (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
CA2068222A1 (en) Monoclonal antibodies
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
IL93941A0 (en) Retinoblastoma gene product antibodies and their use in cancer prognosis
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
NO903788D0 (no) Monoklonalt antistoff mot protein c.